Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$734K Buy
5,712
+252
+5% +$29.5K 0.2% 117
2026
Q1
$657K Buy
5,460
+1,785
+49% +$206K 0.21% 118
2025
Q4
$387K Buy
3,675
+32
+0.9% +$3K 0.13% 187
2025
Q3
$306K Buy
3,643
+150
+4% +$12.4K 0.11% 216
2025
Q2
$277K Sell
3,493
-1,362
-28% -$108K 0.11% 208
2025
Q1
$436K Sell
4,855
-540
-10% -$50.4K 0.19% 141
2024
Q4
$537K Buy
+5,395
New +$556K 0.15% 111

Other funds holding MRK

Alteri Wealth's MRK Position: Q2 2026 in Review

Alteri Wealth increased its Merck (MRK) stake by 4.6% in Q2 2026, buying an estimated $29.5K and bringing the position to 5,712 shares worth $734K. The position accounts for 0.2% of the portfolio, ranked #117.

Alteri Wealth first reported a position in MRK in Q4 2024 and has held it in 7 quarters since. 1,867 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Alteri Wealth held 5,712 shares of Merck worth $734K as of Q2 2026.
  • Alteri Wealth bought 252 Merck shares in Q2 2026, an estimated $29.5K.
  • Merck made up 0.2% of Alteri Wealth's portfolio in Q2 2026, its #117 holding.
  • Alteri Wealth first reported a position in Merck in Q4 2024 and has held it in 7 quarters since.
  • 1,867 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Alteri Wealth's 13F filing for Q2 2026, filed 29 Jul 2026.